TLR9 and fetal growth restriction: Oliveira and colleagues conducted pioneering research demonstrating that IUGR programs alterations in circulating mitochondrial DNA (mtDNA)/Toll-like receptor 9 (TLR9) content, leading to elevated tumor necrosis factor-alpha (TNF-α) levels and a persistent pro-inflammatory state (Oliveira et al., 2017a).